Prevalence of Prostate Cancer Among Men With a Prostate-Specific Antigen Level ≤4.0 Ng Per Milliliter

New England Journal of Medicine - United States
doi 10.1056/nejmoa031918
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

Prognosis of Prostate Cancer With Initial Prostate-Specific Antigen ≫1,000 Ng/mL at Diagnosis

OncoTargets and Therapy
OncologyPharmacology
2017English

Hemodilution of Prostate-Specific Antigen Levels Among Obese Men

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2009English

Assessment of the Relationship Between Serum Prostate-Specific Antigen Level and Serum Fasting Glucose, Total Cholesterol and Neutrophil-Lymphocyte Ratio in Men Aged 50-70 Years With Prostate-Specific Antigen Level 0-10 Ng/mL Without Prostate Cancer Diagnosis

Üroonkoloji Bülteni
2018English

Prostate-Specific Antigen Velocity in a Prospective Prostate Cancer Screening Study of Men With Genetic Predisposition

British Journal of Cancer
Cancer ResearchOncology
2018English

Association of Nadir Prostate-Specific Antigen >0.5 Ng/mL After Dose-Escalated External Beam Radiation With Prostate Cancer-Specific Endpoints

Cureus
2018English

Plasma Carotenoids and Tocopherols in Relation to Prostate-Specific Antigen (PSA) Levels Among Men With Biochemical Recurrence of Prostate Cancer

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2015English

Long-Term Outcomes of Radical Prostatectomy With Multimodal Adjuvant Therapy in Men With a Preoperative Serum Prostate-Specific Antigen Level ≥50 Ng/mL

Cancer
Cancer ResearchOncology
2008English

Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Prostate Specific Antigen Screening Among Men in Abakaliki, South East Nigeria

Open Journal of Urology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy